112190-24-6 Usage
Description
(2R,3R,4R,5S)-6-cyclohexyl-3,4-dihydroxy-5-[(2S)-3-(1H-imidazol-5-yl)-2-[(naphthalen-1-yloxy)acetyl]aminopropanoyl]amino-2-(1-methylethyl)-N-(1S,2S)-2-methyl-1-[(pyridin-2-ylmethyl)carbamoyl]butylhexanamide (non-preferred name) is a complex peptide-like compound with a highly specific and intricate chemical structure. It features multiple stereocenters and functional groups, such as hydroxyl, amine, and carbonyl groups, which may contribute to its potential biological activity and therapeutic applications.
Uses
Used in Pharmaceutical Industry:
(2R,3R,4R,5S)-6-cyclohexyl-3,4-dihydroxy-5-[(2S)-3-(1H-imidazol-5-yl)-2-[(naphthalen-1-yloxy)acetyl]aminopropanoyl]amino-2-(1-methylethyl)-N-(1S,2S)-2-methyl-1-[(pyridin-2-ylmethyl)carbamoyl]butylhexanamide (non-preferred name) is used as a potential therapeutic agent for targeting specific receptors or biological pathways due to its complex structure and multiple stereocenters, which may allow for precise interactions with biological targets.
Check Digit Verification of cas no
The CAS Registry Mumber 112190-24-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,1,9 and 0 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 112190-24:
(8*1)+(7*1)+(6*2)+(5*1)+(4*9)+(3*0)+(2*2)+(1*4)=76
76 % 10 = 6
So 112190-24-6 is a valid CAS Registry Number.
112190-24-6Relevant articles and documents
Inhibitors of the Protease from Human Immunodeficiency Virus: Design and Modeling of a Compound Containing a Dihydroxyethylene Isostere Insert with High Binding Affinity and Effective Antiviral Activity
Thaisrivongs, Suvit,Tomasselli, Alfredo G.,Moon, Joseph B.,Hui, John,McQuade, Thomas J.,et al.
, p. 2344 - 2356 (2007/10/02)
The peptidomimetic template and the dihydroxyethylene isostere insert that were applied successfully to the design of renin inhibitors have been extended to the related protease from human immunodeficiency virus (HIV).The present report describes the stru